April 14, 2015

Diplomat Pharmacy announced it will distribute Novartis' new medicine Jadenu, which is indicated to treat patients with chronic iron overload. 

April 3, 2015

Diplomat Pharmacy on Friday celebrated 40 years of service. 

April 2, 2015

Diplomat Pharmacy on Wednesday completed its acquisition of BioRx. 

April 1, 2015

Diplomat Pharmacy raised almost $200 million in follow-on public offering that closed Tuesday. 

March 24, 2015

Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.

March 18, 2015

Diplomat Pharmacy to offer PARI’s cystic fibrosis treatment Kitabis Pak together with a PARI LC Plus nebulizer handset.

March 16, 2015

Diplomat Pharmacy is looking to raise $200 million with a proposed follow-on public offering of its common stock.

February 26, 2015

Diplomat Pharmacy on Thursday acquired the specialty pharmacy BioRx.

 

February 25, 2015

Diplomat Pharmacy to dispense new multiple myeloma treatment from Novartis. 

February 23, 2015

Diplomat Pharmacy's Phil and Jocelyn Hagerman gift $5 million to the Ferris State University’s College of Pharmacy. 

February 3, 2015

Diplomat Pharmacy announced Monday that it has earned the Verified Internet Pharmacy Practice Sites seal of approval from the National Association of Boards of Pharmacy.

January 30, 2015

Diplomat Pharmacy announced Thursday that the Food and Drug Administration has approved an expanded indication of Imbruvica (ibrutinib) for the treatment of Waldenström’s macroglobulinemia (WM).

January 20, 2015

Diplomat Pharmacy on Tuesday announced the addition of Susan Faust to their senior leadership team as VP specialty infusion and market development.

December 29, 2014

Diplomat Pharmacy has announced that Jennifer Hagerman will take office as the president of the Michigan Pharmacists Association.

December 23, 2014

Specialty pharmacy Diplomat Pharmacy has announced that it will stock Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets), which was approved Dec. 19 by the Food and Drug Administration.

December 11, 2014

Diplomat announced a new partnership with Novation through their Hospital Specialty Rx Program on Thursday.

December 4, 2014

Diplomat Pharmacy announced Wednesday that it has been selected to Pfizer's limited-distribution panel for Xalkori, Bosulif, Inlyta and Sutent.

November 6, 2014

Diplomat Pharmacy on Wednesday announced the addition of Martino Luu to their senior leadership team as VP innovation and process improvement.

 

October 10, 2014

Shares of Diplomat Pharmacy officially began trading on Friday at a price that had reached more than $17 per share in mid-afternoon trading.

 

October 1, 2014

Diplomat on Tuesday announced that Stephen Brown has been named chief information officer.

September 29, 2014

Diplomat Pharmacy on Monday announced that it has commenced its initial public offering of 13.3 million shares of its common stock.

 

September 12, 2014

Diplomat on Wednesday announced that it is partnering with area leaders to provide the necessary funding to expand Dr. Phil Zimbardo's Hero Imagination Project to the Flint, Mich., area.

August 8, 2014

Diplomat on Thursday announced that its president, Gary Kadlec, has been elected to the board of directors for the American Foundation of Pharmaceutical Education. 

July 17, 2014

Diplomat announced it has acquired MedPro Rx, a specialty pharmacy focused on specialty infusion therapies including hemophilia and immune globulin.